title: Advisory panel hears contradictory evidence, backs keeping troglitazone on market.
authors.forename: J L
authors.initials: JL
authors.lastname: Miller
mesh_terms: D002839:Chromans / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D003253:Consultants; D016903:Drug Monitoring; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D017093:Liver Failure / Q000139:chemically induced*; D013844:Thiazoles / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D045162:Thiazolidinediones; D000077288:Troglitazone; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D002839:Chromans; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D000077288:Troglitazone